Home/Pipeline/Digital Biomarker Development & Validation

Digital Biomarker Development & Validation

Neurological and Rare Disorders

N/A (Technology Development)Active

Key Facts

Indication
Neurological and Rare Disorders
Phase
N/A (Technology Development)
Status
Active
Company

About Biosensics

Biosensics is a pioneering private company in the wearable medical device and digital health space, with over 17 years of research and development. Its core business is providing validated wearable sensor technologies and digital platforms to pharmaceutical companies and researchers for objective endpoint measurement in clinical trials, particularly in neurology and rare diseases. The company operates on a B2B model, generating revenue through product sales and services, and leverages strong academic-industry partnerships for research and commercialization. While financially opaque as a private entity, its established product use in trials and with older adults suggests it is a revenue-generating company.

View full company profile